Study of Prophylactic Vs Preemptive Valganciclovir
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This is a study of prophylactic Vs preemptive oral valganciclovir for management of
cytomegalovirus infection in adult renal transplant recipients looking at clinical and
pharmacoeconomic outcomes